Premium
HUMAN CHORIONIC SOMATOMAMMOTROPHIN RADIOIMMUNOASSAY IN EVALUATION OF PLACENTAL FUNCTION
Author(s) -
Genazzani A. R.,
Cocola F.,
Casoli M.,
Mello G.,
Scarselli G.,
Neri P.,
Fioretti P.
Publication year - 1971
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.1971.tb00320.x
Subject(s) - radioimmunoassay , medicine , abortion , obstetrics , fetal distress , placenta , pregnancy , fetus , pathological , threatened abortion , endocrinology , biology , genetics
Summary In order to investigate the use of radioimmunoassay of human chorionic somato‐mammotrophin (HCS) for the evaluation of the placenta function, 502 pregnant women (660 assays) were examined. The patients were divided into groups: normal pregnancy, commencement of labour, threatened abortion, impending abortion, rhesus isosensitization, placenta praevia, diabetes, premature labour, pre‐eclampsia, intrauterine fetal death, twins, large and small‐for‐babies, obesity, and prolonged pregnancy with or without fetal postmaturity or chronic fetal distress. The results obtained sustain the clinical application of HCS radioimmunoassay as an index of placental function in cases of physiological and pathological pregnancies.